Mr James J Plunkett, MD | |
7055 N Fresno St, Fresno, CA 93720-2957 | |
(559) 449-9977 | |
Not Available |
Full Name | Mr James J Plunkett |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7055 N Fresno St, Fresno, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003867987 | NPI | - | NPPES |
00G613280 | Other | CA | BS OF CA |
00G613280 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | G61328 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr James J Plunkett, MD Po Box 45123, San Francisco, CA 94145-0123 Ph: (209) 956-7725 | Mr James J Plunkett, MD 7055 N Fresno St, Fresno, CA 93720-2957 Ph: (559) 449-9977 |
News Archive
Oramed Pharmaceuticals Inc. announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.
A team of chemists and biologists at the Institute of Transformative Bio-Molecules, Nagoya University have succeeded in finding new molecules that change the circadian rhythm in mammals by applying synthetic chemistry methods, which makes use of highly selective metal catalysts.
The world's largest congress dedicated to the epidemiology, pathogenesis, prevention, and treatment of osteoporosis and osteoarthritis has opened today in Rome, Italy with 4500 delegates.
Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the alternative energy industry, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it is entering the final phase of its commercialization program for its first cell culturing devices for the StemDisc family of stem cell culturing products.
Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the Phase I trial, which is being conducted at the NIH Clinical Center in Bethesda, Md.
› Verified 8 days ago
William B Etiz, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1303 E Herndon Ave, Fresno, CA 93720 Phone: 559-450-3000 | |
Yang J Kim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1303 E Herndon Ave, Fresno, CA 93720 Phone: 559-450-3000 | |
John S Sturman, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1303 E Herndon Ave, Fresno, CA 93720 Phone: 559-450-3000 | |
Gregory Alan Smith, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5680 N Fresno St Ste 105, Fresno, CA 93710 Phone: 559-374-5130 Fax: 888-977-4918 | |
Rasheed Amireh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1630 E Herndon Ave, Fresno, CA 93720 Phone: 559-447-1432 Fax: 559-432-2874 | |
Andre S Motie, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1303 E Herndon Ave, Fresno, CA 93720 Phone: 559-450-3000 |